DaVita
DVA
#2005
Rank
NZ$16.94 B
Marketcap
NZ$237.00
Share price
5.44%
Change (1 day)
-24.68%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$16.58. In 2024 the company made an earnings per share (EPS) of NZ$18.40 an increase over its 2023 EPS that were of NZ$12.70.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-6.75%
2024NZ$18.4044.94%
2023NZ$12.7027.26%
2022NZ$9.98-35.56%
2021NZ$15.4844.1%
2020NZ$10.7419.7%
2019NZ$8.98540.48%
2018NZ$1.40-76.07%
2017NZ$5.86-19.31%
2016NZ$7.26242.52%
2015NZ$2.12-62.87%
2014NZ$5.7113.43%
2013NZ$5.038.45%
2012NZ$4.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$35.62 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.10 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$24.52 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.17-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA